Panel: 340
Future-Proofing Health Innovations: A Collaborative Approach to Better Policy, Governance and Regulatory Requirements for Advanced Therapeutics
Panel Abstract:
Imagine a future where Canada has developed a cure for diabetes, or treatments that stop or delay the progression of muscular dystrophy and Alzheimer’s. And now imagine that, as a country, we cannot get that treatment to market – to patients – because of red tape. This imagined future is not far off – and Canada needs to be prepared. The rapid pace of medical innovation, especially in cell and gene therapy and regenerative medicine, will bring groundbreaking treatments to some of the most devastating diseases. This, in turn, demands regulatory innovation to improve public access to new therapies while also addressing high development costs, inaccessible prices, and lagging reimbursement policies. Join Canada’s Stem Cell Network and ThéCell as they host an interactive discussion to explore the topics of regulation, patient access, and affordability, with the goal of informing a strong, inclusive, and flexible regulatory framework for Canada’s future.
Summary of Conversations:
Coming soon!